CHRISTINE STEINBERG: Open Payments
NPI 1740843465 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 23 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $216 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $113 |
| BIOTRONIK NRO, Inc. | 3 | $82 |
| SCILEX PHARMACEUTICALS INC. | 3 | $52 |
| IBSA Pharma Inc. | 3 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $30 |
| Foundation Fusion Solutions, LLC | 1 | $23 |
Products named: XTAMPZA, Prospera, Tirosint, HORIZANT, ZTLido, JOURNAVX, ELYXYB - CELECOXIB, QULIPTA.
Industry payments across NJ — which companies pay providers there.
